Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
44
pubmed:dateCreated
1996-12-26
pubmed:abstractText
The expression by T lymphocytes (T cells) of more than one of the functionally distinct subtypes of prostaglandin E2 (PGE2) receptors (Rs), designated EP1, EP2, EP3, and EP4 Rs, is a principal determinant of specificity and diversity of the immune effects of PGE2. The cultured line of human leukemic T cells, termed HSB.2, co-expresses a total of 7282 +/- 1805 EP3, EP4, and EP2 Rs per cell with a Kd of 3.7 +/- 1.4 nM (mean +/- S.E., n = 9). The EP3/EP1 R-selective agonist sulprostone, EP3/EP2/EP4 R-selective agonists M&B 28767 and misoprostol, and EP2 R-selective agonist butaprost but not the EP1 R-selective antagonist SC-19220 competitively inhibited the binding of [3H]PGE2 to HSB.2 cells. Stimulation of increases in the intracellular concentration of cyclic AMP ([cAMP]i) by PGE2, misoprostol, and butaprost and of increases in the intracellular concentration of calcium ([Ca2+]i) by PGE2 and sulprostone demonstrated the respective involvement of EP2/EP4 Rs and EP3 Rs in transduction of biochemical signals. Matrix metalloproteinase (MMP)-9 was identified by zymography and Western blots as the principal MMP secreted by HSB.2 cells. The cytosolic level and secretion of MMP-9 were increased maximally after 24 h of incubation of HSB.2 cells with 10(-8)-10(-6) M PGE2, sulprostone, M&B 28767, and misoprostol but not with 10(-6) M PGF2alpha, PGD2, PGI2, or butaprost, suggesting a principal dependence on EP3 Rs. That stimulation of MMP-9 secretion by PGE2 was not diminished in Ca2+-free medium but was suppressed significantly and dose-dependently by thapsigargin, an inhibitor of endomembrane Ca2+-ATPase, suggested that MMP-9 expression by HSB.2 cells is mediated by increases in [Ca2+]i attributable to release of Ca2+ from intracellular stores. The lack of effect of dibutyryl cAMP, forskolin, and SQ 22536, an adenylyl cyclase inhibitor, on MMP-9 secretion by HSB.2 cells argued against any role for cAMP-dependent mechanisms linked to EP2/EP4 Rs. Cycloheximide and actinomycin D, which respectively inhibited protein and RNA synthesis, suppressed basal and PGE2 induction of MMP-9 production by HSB.2 cells. Northern analysis indicated that PGE2 and sulprostone time-dependently increased expression of MMP-9 mRNA. Thus, stimulation of MMP-9 in HSB.2 T cells by PGE2 is attributable to [Ca2+]i-dependent EP3 R-mediation of increases in message transcription.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
http://linkedlifedata.com/resource/pubmed/chemical/11-deoxy-16-phenoxy-17,18,19,20-tetr..., http://linkedlifedata.com/resource/pubmed/chemical/9-(tetrahydro-2-furyl)-adenine, http://linkedlifedata.com/resource/pubmed/chemical/Adenine, http://linkedlifedata.com/resource/pubmed/chemical/Alprostadil, http://linkedlifedata.com/resource/pubmed/chemical/Bucladesine, http://linkedlifedata.com/resource/pubmed/chemical/Calcium, http://linkedlifedata.com/resource/pubmed/chemical/Collagenases, http://linkedlifedata.com/resource/pubmed/chemical/Cyclic AMP, http://linkedlifedata.com/resource/pubmed/chemical/Cycloheximide, http://linkedlifedata.com/resource/pubmed/chemical/Dactinomycin, http://linkedlifedata.com/resource/pubmed/chemical/Dinoprostone, http://linkedlifedata.com/resource/pubmed/chemical/Enzyme Inhibitors, http://linkedlifedata.com/resource/pubmed/chemical/Forskolin, http://linkedlifedata.com/resource/pubmed/chemical/Matrix Metalloproteinase 9, http://linkedlifedata.com/resource/pubmed/chemical/Misoprostol, http://linkedlifedata.com/resource/pubmed/chemical/Prostaglandins E, Synthetic, http://linkedlifedata.com/resource/pubmed/chemical/RNA, Messenger, http://linkedlifedata.com/resource/pubmed/chemical/Receptors, Prostaglandin E, http://linkedlifedata.com/resource/pubmed/chemical/Thapsigargin, http://linkedlifedata.com/resource/pubmed/chemical/butaprost, http://linkedlifedata.com/resource/pubmed/chemical/sulprostone
pubmed:status
MEDLINE
pubmed:month
Nov
pubmed:issn
0021-9258
pubmed:author
pubmed:issnType
Print
pubmed:day
1
pubmed:volume
271
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
27744-50
pubmed:dateRevised
2007-11-14
pubmed:meshHeading
pubmed-meshheading:8910368-Adenine, pubmed-meshheading:8910368-Alprostadil, pubmed-meshheading:8910368-Blotting, Northern, pubmed-meshheading:8910368-Bucladesine, pubmed-meshheading:8910368-Calcium, pubmed-meshheading:8910368-Cell Line, pubmed-meshheading:8910368-Collagenases, pubmed-meshheading:8910368-Cyclic AMP, pubmed-meshheading:8910368-Cycloheximide, pubmed-meshheading:8910368-Dactinomycin, pubmed-meshheading:8910368-Dinoprostone, pubmed-meshheading:8910368-Enzyme Inhibitors, pubmed-meshheading:8910368-Forskolin, pubmed-meshheading:8910368-Gene Expression Regulation, Enzymologic, pubmed-meshheading:8910368-Gene Expression Regulation, Neoplastic, pubmed-meshheading:8910368-Humans, pubmed-meshheading:8910368-Kinetics, pubmed-meshheading:8910368-Leukemia, T-Cell, pubmed-meshheading:8910368-Matrix Metalloproteinase 9, pubmed-meshheading:8910368-Misoprostol, pubmed-meshheading:8910368-Prostaglandins E, Synthetic, pubmed-meshheading:8910368-RNA, Messenger, pubmed-meshheading:8910368-Receptors, Prostaglandin E, pubmed-meshheading:8910368-T-Lymphocytes, pubmed-meshheading:8910368-Thapsigargin, pubmed-meshheading:8910368-Transcription, Genetic, pubmed-meshheading:8910368-Tumor Cells, Cultured
pubmed:year
1996
pubmed:articleTitle
Regulation of expression of matrix metalloproteinase-9 in early human T cells of the HSB.2 cultured line by the EP3 subtype of prostaglandin E2 receptor.
pubmed:affiliation
Department of Medicine, University of California Medical Center, San Francisco, California 94143-0711, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S.